.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Citi
Medtronic
Cerilliant
Harvard Business School
Cantor Fitzgerald
Federal Trade Commission
Covington
Fuji
Mallinckrodt

Generated: June 24, 2017

DrugPatentWatch Database Preview

PEDIAMYCIN 400 Drug Profile

« Back to Dashboard

What is the patent landscape for Pediamycin 400, and what generic Pediamycin 400 alternatives are available?

Pediamycin 400 is a drug marketed by Arbor Pharms Llc and is included in one NDA.

The generic ingredient in PEDIAMYCIN 400 is erythromycin ethylsuccinate. There are ninety-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for Tradename: PEDIAMYCIN 400

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list21
Clinical Trials: see list2,204
Patent Applications: see list533
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PEDIAMYCIN 400 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
PEDIAMYCIN 400
erythromycin ethylsuccinate
SUSPENSION;ORAL062304-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
QuintilesIMS
Johnson and Johnson
McKinsey
Baxter
Queensland Health
Novartis
Chinese Patent Office
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot